CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 4 Grant or award Chief Financial Officer acquired 43,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Financial Officer acquired 10,000 shares (option exercise)
- 4 Option exercise President and CEO acquired 20,000 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 3,000 shares at $6.49 ($19,476)
- 4/A Grant or award President and CEO acquired 5,500 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 4,620 shares (grant or award)
- 4 Grant or award President and CEO acquired 5,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 4,070 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 4,620 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale President and CEO sold 24,337 shares at $9.37 ($228,026)
- 4 Open-market sale President and CEO sold 11,418 shares at an average $14.65 ($167,246)
- 4 Open-market sale Director sold 26,000 shares at $14.47 ($376,282)
- 4 Open-market sale Chief Operating Officer sold 20,000 shares at $14.00 ($280,000)
- 4 Open-market sale Chief Operating Officer sold 9,565 shares at $13.00 ($124,345)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $13.50 ($135,000)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $12.54 ($125,364)
- 4 Open-market sale Chief Operating Officer sold 10,435 shares at an average $13.06 ($136,263)
- 4 Open-market sale Chief Operating Officer sold 20,000 shares at $12.00 ($240,000)
Page 8 of 20 · 395 filings